CoChat

Characterization of the kynurenine pathway in NSC‐34 cell line: implications for amyotrophic lateral sclerosis

Chen, Yiquan, Brew, Bruce J., Guillemin, Gilles J. · 2011 · Journal of Neurochemistry
Cited by 68

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

J. Neurochem.(2011)118, 816–825. Amyotrophic lateral sclerosis (ALS) is the most common type of motor neuron degenerative disease for which the aetiology is still unknown. The kynurenine pathway (KP) is a major degradative pathway of tryptophan ultimately leading to the production of NAD+and is also one of the major regulatory mechanisms of the immune response. The KP is known to be involved in several neuroinflammatory disorders. Among the KP intermediates, quinolinic acid (QUIN) is a potent excitotoxin, while kynurenic acid and picolinic acid are both neuroprotectant. This study aimed to (i) characterize the components of the KP in NSC‐34 cells (a rodent motor neuron cell line) and (ii) assess the effects of QUIN on the same cells. RT‐PCR and immunocytochemistry were used to characterize the KP enzymes, and lactate dehydrogenase (LDH) test was used to assess the effect of QUIN in the absence and presence of NMDA receptor antagonists, kynurenines and 1‐methyl tryptophan. Our data demonstrate that a functional KP is present in NSC‐34 cells. LDH tests showed that (i) QUIN toxicity on NSC‐34 cells increases with time and concentration; (ii) NMDA antagonists, 2‐amino‐5‐phosphonopentanoic acid, MK‐801 and memantine, can partially decrease QUIN toxicity; (iii) kynurenic acid can decrease LDH release in a linear manner, whereas picolinic acid does the same but non‐linearly; and (iv) 1‐methyl tryptophan is effective in decreasing QUIN release by the rodent microglial cell line BV‐2 and thus protects NSC‐34 from cell death. There is currently a lack of effective treatment for ALS and our in vitro results provide a novel therapeutic strategy for ALS patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2010.07159.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 68

Metadata

Authors
Chen, Y., Brew, B. J., & Guillemin, G. J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2011-01-28
Volume
118
Issue
5
Pages
816-825
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1603819614
Cited by
68
References
8
FWCI
0.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of the kynurenine pathway in NSC‐34 cell line: implications for amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1111/j.1471-4159.2010.07159.x
The paper
Chen, Y., Brew, B. J., & Guillemin, G. J. (2011). Characterization of the kynurenine pathway in NSC‐34 cell line: implications for amyotrophic lateral sclerosis. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2010.07159.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.